hx4 pharm 11

Upload: saubie-aslamiah

Post on 07-Apr-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/3/2019 HX4 pharm 11

    1/15

  • 8/3/2019 HX4 pharm 11

    2/15

    Objectives

    After working through this module, you should be able

    to:

    Explain the immunological mechanisms underlyingtype IV hypersensitivity reaction.

    Describe the principal causes and symptomsassociated with type IV hypersensitivity reactions.

  • 8/3/2019 HX4 pharm 11

    3/15

    Type IV Hypersensitivity

    Type IV hypersensitivity is also known as delayed

    type hypersensitivity

    It is different from the other 3 types ofhypersensitivity as it represents tissue damageresulting from inappropriate cell-mediated

    immunity reactions

    Clinical conditions - tuberculosis, leprosy, contact

    dermatitis

  • 8/3/2019 HX4 pharm 11

    4/15

    Type IV hypersensitivity

    T cell

    Antigen

    ILs

    Macrophage

    Cytokines

    Target cell

  • 8/3/2019 HX4 pharm 11

    5/15

    Type IV Hypersensitivity

    Initiated by the interaction of antigen with primed

    T-lymphocytes and subsequently the release ofsoluble cytokines from the T lymphocytes which

    activate macrophages

    Activated macrophages may differentiate into

    giant cells and develops into granulomantous

    hypersensitivity

  • 8/3/2019 HX4 pharm 11

    6/15

    Type IV Hypersensitivity

    Within the type IV response there are 4 different

    phenomena which rarely occur separately. Theseare:

    i. Jones-mote reaction

    ii. Contact hypersensitivity

    iii. Tuberculin reaction

    iv. Granulomatous reaction

  • 8/3/2019 HX4 pharm 11

    7/15

    Type IV Hypersensitivity

    i. Jones-mote reaction

    - induced by contact with allergen but is

    characterized by the infiltration of basophilsinto the inflammatory site.

    - the factors which cause this particular

    component of the reaction are unknown

  • 8/3/2019 HX4 pharm 11

    8/15

  • 8/3/2019 HX4 pharm 11

    9/15

    Type IV Hypersensitivity

    iii. Tuberculin reaction

    This type of hypersensitivity is the basis of the

    Mantoux Test ( 72 hours- check for hard at

    injection site)

    The basis of tuberculin response is the re-activation of antigen-specific memory T cellswithin the dermal layer of the skin

  • 8/3/2019 HX4 pharm 11

    10/15

    Type IV Hypersensitivity

    iii. Tuberculin reaction (cont)

    T cells produce TNF- local vascularendothelial cells induce infiltration ofneutrophils into the skin

    Predominant infiltrating cells mononuclearleukocytes (lymphocytes and monocytes)

    reaching a peak at about 48 hours

  • 8/3/2019 HX4 pharm 11

    11/15

    Type IV Hypersensitivity

    iii. Tuberculin reaction (cont)

    Characteristic induration is a result of

    combination of large number cells with oedema

    Signs of reaction resolve after 5-7 days

    In contrast to infection with constant source of

    infection, reaction progresses to granulomatous

    lesion

  • 8/3/2019 HX4 pharm 11

    12/15

    Type IV Hypersensitivity

    iv. Granulomatous reaction

    Alternative name for granulomatous

    hypersensitivity is chronic inflammation

    Hallmark of chronic inflammation is mononuclear

    cells (monocytes, macrophages, lymphocytes)

    This type of DTH has most severe consequences

    due to presence of often extensive tissue damage

  • 8/3/2019 HX4 pharm 11

    13/15

    Type IV Hypersensitivity

    iv. Granulomatous reaction (cont)

    2 types of granuloma:

    - foreign-body granuloma:

    initiated by inert foreign bodies

    - immune granuloma:

    T cell-mediated reaction to immunogenic

    particles

  • 8/3/2019 HX4 pharm 11

    14/15

    Type IV Hypersensitivity

  • 8/3/2019 HX4 pharm 11

    15/15

    References

    Roderick Nairn and Matthew Helbert. Immunology for Medical

    Students. Elsevier Mosby. 2003.

    Stites DP, Terr Al and Parslow TG. Medical Immunology. 10th Edition,Appleton & Lange, Prentice-hall International Inc. 2001.

    Roitt I, Brostoff J and Male D. Immunology. 6th Edition, GowerMedical Publishing, London. 2001

    Cedric Mims, Hazel M. Dockrell, Richard V.Goering, Ivan Roitt, Derek

    Wakelin and Mark Zuckerman. Medical Microbiology. 3rd

    Edition,Elsevier Mosby. 2004.

    Marjorie Kelly Cowan and Kathleen Park Talaro. Microbiology ASystems Approach. McGraw-Hill. 2006.